脂质纳米粒子技术的影响和预期:从细胞向到有机细胞向
Yusuke Sato1, Takashi Nakamura1, Yuma Yamada1
1Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan.
概括
脂质纳米颗粒 (LNP) 正在推进用于疫苗和癌症治疗的mRNA输送. 本次审查强调了LNP工程的安全性,生物分布,以及癌症免疫学和向治疗中的应用.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- mRNA疫苗的成功凸显了脂质纳米粒子 (LNP) 在mRNA输送方面的潜力.
- 为了提高安全性和控制生物分布,正在设计LNP技术.
研究的目的:
- 审查mRNA疫苗和癌症免疫学的LNP技术的进展.
- 探索LNP在构建纳米药物递送系统 (DDS) 中的应用,以评估癌症免疫周期.
- 讨论下一代DDS,包括器官向系统.
主要方法:
- 使用脂质库设计可离子化脂质以优化LNP属性.
- 将LNP的进展应用于癌症免疫学,并开发纳米-DDS.
- 研究抗原和辅助剂输送策略,以增强癌症免疫循环.
- 在癌症免疫疗法和MITO-Porter系统中引入NK细胞向.
主要成果:
- 在安全性,生物分布和mRNA疫苗应用方面,LNP工程的进展.
- 开发一种潜在的纳米-DDS来评估瘤微环境中的免疫状态.
- 在细胞治疗中展示了MITO-Porter系统的线粒体向输送.
结论:
- 对于推进mRNA疫苗和癌症免疫治疗来说,LNP技术至关重要.
- 针对性输送系统,如MITO-Porter,为心肌病等疾病提供了新的治疗策略.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


